Doron Lipson
Molecular Biology · 2007–2021
A researcher in the Science corpus: 9 papers; trusts 2 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 104 citations into it
Whom Doron Lipson trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts Doron Lipson overall
Papers from Doron Lipson's perspective
Ordered by how strongly the researchers Doron Lipson trusts endorse each paper. Same corpus, a different order for every researcher.
- BioProspector: Discovering Conserved DNA Motifs in Upstream Regulatory Regions of Co-Expressed Genes (Pacific Symposium on Biocomputing)
- Genome-wide location and function of DNA binding proteins. (Science)
- An algorithm for finding protein–DNA binding sites with applications to chromatin-immunoprecipitation microarray experiments (Nature Biotechnology)
- Fitting a Mixture Model By Expectation Maximization To Discover Motifs In Biopolymer
- Transcriptional regulatory code of a eukaryotic genome (Nature)
- A gene atlas of the mouse and human protein-encoding transcriptomes. (Proceedings of the National Academy of Sciences of the United States of America)
- Genome-wide mapping of Polycomb target genes unravels their roles in cell fate transitions. (Genes & Development)
- Gene expression profiling predicts clinical outcome of breast cancer
- Promoter-specific binding of Rap1 revealed by genome-wide maps of protein–DNA association (Nature Genetics)
- An improved map of conserved regulatory sites for Saccharomyces cerevisiae (BMC Bioinformatics)
Their papers
- Mapping information-rich genotype-phenotype landscapes with genome-scale Perturb-seq (2021) — 669 citations
- Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing (2013) — 2,044 citations
- Discovering Motifs in Ranked Lists of DNA Sequences (2007) — 740 citations
- GOrilla: a tool for discovery and visualization of enriched GO terms in ranked gene lists (2009) — 635 citations
- Blood-based tumor mutational burden as a predictor of clinical benefit in non-small-cell lung cancer patients treated with atezolizumab (2018) — 1,039 citations
- Activation of MET via diverse exon 14 splicing alterations occurs in multiple tumor types and confers clinical sensitivity to MET inhibitors. (2015) — 714 citations
- Emergence of constitutively active estrogen receptor-α mutations in pretreated advanced estrogen receptor positive breast cancer (2014) — 595 citations
- Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies (2012) — 867 citations
- Global organization of replication time zones of the mouse genome. (2008) — 160 citations